Cargando…
A potential novel option for cancer immunotherapy – TLR7 stimulation inhibits malignant melanoma bone invasion
Autor principal: | Katagiri, Takenobu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6112761/ https://www.ncbi.nlm.nih.gov/pubmed/30159120 http://dx.doi.org/10.18632/oncotarget.25872 |
Ejemplares similares
-
The inhibition of malignant melanoma cell invasion of bone by the TLR7 agonist R848 is dependent upon pro-inflammatory cytokines produced by bone marrow macrophages
por: Manome, Yoko, et al.
Publicado: (2018) -
TLR8: No gain, no pain
por: Barrat, Franck J.
Publicado: (2018) -
IRAK4 inhibition to shut down TLR signaling in autoimmunity and MyD88-dependent lymphomas
por: Küppers, Ralf
Publicado: (2015) -
Glial tauopathy: Neurons optional?
por: Walker, Lary C.
Publicado: (2019) -
Critical Roles of NF-κB Signaling Molecules in Bone Metabolism Revealed by Genetic Mutations in Osteopetrosis
por: Jimi, Eijiro, et al.
Publicado: (2022)